National Health Investors (NYSE:NHI) Price Target Raised to $86.00

National Health Investors (NYSE:NHI) had its target price boosted by Wells Fargo & Company from $85.00 to $86.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an equal weight rating on the real estate investment trust’s stock.

Several other research analysts have also recently issued reports on the company. Deutsche Bank Aktiengesellschaft cut National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price target for the company. in a research note on Tuesday, January 20th. National Bank Financial set a $85.00 price objective on shares of National Health Investors in a research note on Tuesday, January 20th. KeyCorp upped their price objective on shares of National Health Investors from $80.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, December 4th. Cantor Fitzgerald set a $85.00 target price on shares of National Health Investors in a research report on Monday, January 5th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a research note on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $86.83.

National Health Investors Stock Performance

NHI opened at $82.30 on Friday. The business’s 50 day moving average is $84.55 and its 200-day moving average is $79.81. The stock has a market cap of $3.99 billion, a PE ratio of 27.25, a price-to-earnings-growth ratio of 4.45 and a beta of 0.65. The company has a current ratio of 6.90, a quick ratio of 6.90 and a debt-to-equity ratio of 0.76. National Health Investors has a twelve month low of $66.41 and a twelve month high of $91.38.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.01). National Health Investors had a return on equity of 9.56% and a net margin of 37.81%.The business had revenue of $105.82 million for the quarter, compared to analyst estimates of $95.12 million. During the same quarter in the prior year, the firm posted $1.24 earnings per share. The business’s quarterly revenue was up 6.8% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. On average, analysts predict that National Health Investors will post 4.41 earnings per share for the current year.

National Health Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Tuesday, March 31st will be paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.5%. The ex-dividend date of this dividend is Tuesday, March 31st. National Health Investors’s payout ratio is currently 121.85%.

Institutional Trading of National Health Investors

Institutional investors have recently modified their holdings of the company. NewEdge Advisors LLC boosted its stake in National Health Investors by 28.7% during the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after buying an additional 345 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock worth $18,460,000 after acquiring an additional 21,851 shares in the last quarter. Jane Street Group LLC lifted its holdings in National Health Investors by 1,728.4% in the 1st quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock valued at $5,148,000 after acquiring an additional 65,885 shares during the last quarter. Creative Planning lifted its holdings in National Health Investors by 2.2% in the 2nd quarter. Creative Planning now owns 8,217 shares of the real estate investment trust’s stock valued at $576,000 after acquiring an additional 177 shares during the last quarter. Finally, Cetera Investment Advisers boosted its position in shares of National Health Investors by 6.1% during the 2nd quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust’s stock valued at $336,000 after purchasing an additional 275 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.